0001209191-20-011327.txt : 20200220 0001209191-20-011327.hdr.sgml : 20200220 20200220202630 ACCESSION NUMBER: 0001209191-20-011327 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200219 FILED AS OF DATE: 20200220 DATE AS OF CHANGE: 20200220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RINGO WILLIAM R CENTRAL INDEX KEY: 0001238325 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36070 FILM NUMBER: 20637131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001175505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260038620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-365-5600 MAIL ADDRESS: STREET 1: 111 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FIVE PRIME THERAPEUTICS INC DATE OF NAME CHANGE: 20020613 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-19 0 0001175505 FIVE PRIME THERAPEUTICS, INC. FPRX 0001238325 RINGO WILLIAM R 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 1 1 0 0 Chief Executive Officer Employee Stock Option (right to buy) 5.23 2020-02-19 4 A 0 37998 0.00 A 2030-02-18 Common Stock 37998 37998 D This option will vest in its entirety on March 19, 2020, subject to the reporting person's continued service to Five Prime Therapeutics, Inc. through such vest date. /s/ Francis Sarena, Attorney-in-fact 2020-02-20